Watermark
  Back to Search Results

BGB-A317-210

Completed

Tislelizumab in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-210

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT04318080

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2019-002105-22

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan